VERIS Molecular Diagnostic System Sample-To-Sample Crossover Contamination Study
16 May 2014

Sample carry-over and cross-contamination present a high risk for diagnostic medical devices. VERIS was developed to have a false positive rate due to cross contamination of less than 1 in 500 tests with an overall design goal of zero. The objective of this study was to assess the sample-to-sample contamination rate using a real-time PCR assay, characterize potential sources of contamination, and develop system modifications that lead to effectual resolution of carry-over and cross-contamination artifacts.

Show    per page
1 of 1     Page  1 Next 
Quantitative Detection of Hepatitis B Virus (HBV) on the VERIS MDx System hepatitis, eccmid16 May 2014Read
Quantitative Detection of Hepatitis C Virus (HCV) on the VERIS MDx System hepatitis, eccmid16 May 2014Read
Cytomegalovirus (CMV) Viral Load Assay for the VERIS MDx System eccmid, Cytomegalovirus16 May 2014Read
Performance Evaluation of the Beckman Coulter VERIS Cytomegalovirus Assay on the VERIS MDx System eccmid, Cytomegalovirus16 May 2014Read

Popular tags in SelectScience